World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
147
Citations
107691
World Ranking
1258
National Ranking
730

Overview

Michael F. Berger is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics, and Molecular Biology.

The scientist's work extensively covers subfields such as Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, and Pathology and Forensic Medicine.

Key topics in their research include:

  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Lung Cancer Treatments and Mutations
  • Pancreatic and Hepatic Oncology Research
  • Epigenetics and DNA Methylation
  • Cancer Immunotherapy and Biomarkers
  • Acute Myeloid Leukemia Research

Michael F. Berger has contributed to several research publications. Notable recent papers include:

  • "Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers" (2020, Cell)
  • "Cancer therapy shapes the fitness landscape of clonal hematopoiesis" (2020, Nature Genetics)
  • "Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients" (2022, Cell)
  • "Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors" (2021, Nature Communications)
  • "Diverse alterations associated with resistance to KRAS(G12C) inhibition" (2021, Nature)

The scientist frequently publishes in venues such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Nature Communications, and bioRxiv (Cold Spring Harbor Laboratory).

Regular collaborators of Michael F. Berger include:

  • David B. Solit
  • Nikolaus Schultz
  • Marc Ladanyi
  • Ahmet Zehir
  • Zsofia K. Stadler

Best Publications

  • The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Jordi Barretina;Giordano Caponigro;Nicolas Stransky;Kavitha Venkatesan

  • Comprehensivemolecular characterization of clear cell renal cell carcinoma

    Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    Ahmet Zehir;Ryma Benayed;Ronak H Shah;Aijazuddin Syed

  • The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

    N. Stransky;A. M. Egloff;A. D. Tward;A. D. Kostic

  • Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology

    Donavan T. Cheng;Talia N. Mitchell;Ahmet Zehir;Ronak H. Shah

  • Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

    Garrett M Frampton;Alex Fichtenholtz;Geoff A Otto;Kai Wang

  • OncoKB: A Precision Oncology Knowledge Base.

    Debyani Chakravarty;Jianjiong Gao;Sarah Phillips;Ritika Kundra

  • Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    Colin C. Pritchard;Joaquin Mateo;Michael F. Walsh;Navonil De Sarkar

  • Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

    Hira Rizvi;Francisco Sanchez-Vega;Konnor La;Walid Chatila

  • The genomic complexity of primary human prostate cancer

    Michael F. Berger;Michael F. Berger;Michael S. Lawrence;Francesca Demichelis;Yotam Drier

  • Punctuated Evolution of Prostate Cancer Genomes

    Sylvan C Baca;Davide Prandi;Michael S Lawrence;Juan Miguel Mosquera

  • ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

    Weiyi Toy;Yang Shen;Helen Won;Bradley Green

  • Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

    Diego Chowell;Luc G. T. Morris;Claud M. Grigg;Jeffrey K. Weber

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

    Nikhil Wagle;Caroline Emery;Michael F. Berger;Matthew J. Davis

  • Diversity and Complexity in DNA Recognition by Transcription Factors

    Gwenael Badis;Michael F. Berger;Michael F. Berger;Anthony A. Philippakis;Anthony A. Philippakis;Anthony A. Philippakis;Shaheynoor Talukder

  • Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

    Iñigo Landa;Tihana Ibrahimpasic;Laura Boucai;Rileen Sinha

  • Genome-Wide Analysis of ETS-Family DNA-Binding In Vitro and In Vivo

    Gong-Hong Wei;Gwenael Badis;Michael F. Berger;Teemu Kivioja;Teemu Kivioja

  • Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts

    Joshua Z Levin;Michael F Berger;Xian Adiconis;Peter Rogov

Frequent Co-Authors

David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
David M. Hyman
David M. Hyman Memorial Sloan Kettering Cancer Center
Ahmet Zehir
Ahmet Zehir Natera (United States)
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Nikolaus Schultz
Nikolaus Schultz Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Maria E. Arcila
Maria E. Arcila Memorial Sloan Kettering Cancer Center
Barry S. Taylor
Barry S. Taylor Memorial Sloan Kettering Cancer Center
Hikmat Al-Ahmadie
Hikmat Al-Ahmadie Memorial Sloan Kettering Cancer Center
Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine and healthcare increasingly starts with flexible online degree programs. If you are considering a nursing path, a key factor is affordability. Many ask, what is the cheapest online college for nursing? Choosing an affordable option helps reduce student debt while providing access to accredited training.

For current registered nurses aiming to boost qualifications, the rn to bsn online cost is a critical consideration. There are several budget-friendly programs designed to make earning a BSN accessible while working.

Aspiring nurses who hold a different bachelor's degree should consider the non nursing bachelor's to msn online pathway. These accelerated programs allow students to transition quickly into nursing, saving both time and money.

For those seeking advanced roles in healthcare leadership or education, you can explore phd nursing programs online. These programs offer flexibility and affordability, helping you reach higher positions in nursing and academic research.

Best Scientists Citing Michael F. Berger

Trending Scientists

Recently Published Articles